Dermatology NewsAI chatbot ‘hallucinates’ faulty medical intelligenceOctober 19, 2023Infectious DiseasesMixed Topics
Dermatology NewsPilot study: High-dose IL-23 inhibition shows promise for psoriasis remission in some patientsOctober 19, 2023PsoriasisPsoriatic Arthritis
Dermatology NewsPrior authorization software: Saves time but hurdles remainOctober 18, 2023Business of MedicinePractice Management
No association between atopic dermatitis and non-alcoholic fatty liver diseaseOctober 18, 2023Atopic Dermatitis
Dupilumab shows long-term safety and efficacy in severe pediatric atopic dermatitisOctober 18, 2023Atopic Dermatitis
Tralokinumab improves clinical responses at week 16 in moderate-to-severe AD despite IGA 0/1 nonachievementOctober 18, 2023Atopic Dermatitis
Methotrexate reduces epidermal hyperplasia and alters cutaneous IL-31 and IL-31RA expression in ADOctober 18, 2023Atopic Dermatitis
Tacrolimus tops hydrocortisone in pediatric atopic dermatitis treatmentOctober 18, 2023Atopic Dermatitis
Atopic dermatitis affects outcomes in occupational contact dermatitisOctober 18, 2023Atopic Dermatitis
Xyloglucan-pea protein a possible steroid-sparing alternative for treating pediatric ADOctober 18, 2023Atopic Dermatitis
Methotrexate is a safe and efficacious alternative to ciclosporin in children with severe ADOctober 18, 2023Atopic Dermatitis
Children with atopic dermatitis more prone to allergic contact dermatitisOctober 18, 2023Atopic Dermatitis
What’s Eating You? Phlebotomine Sandflies and Leishmania ParasitesOctober 17, 2023Infectious Diseases
Atopic Dermatitis Triggered by Omalizumab and Treated With DupilumabOctober 17, 2023PediatricsAtopic Dermatitis
